Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenues
Contract revenue		$ 2,959,254	$ 3,874,199	$ 8,750,291	$ 5,668,746
Grant revenue			5,476		127,042
Total revenues		2,959,254	3,879,675	8,750,291	5,795,788
Cost of revenues		(2,630,046)	(3,050,814)	(7,204,920)	(4,394,915)
Gross profit		329,208	828,861	1,545,371	1,400,873
Operating expenses:
Research and development		1,177,263	1,259,015	3,433,595	3,731,813
General and administrative		650,762	839,512	2,526,255	2,531,744
Total operating expenses		1,828,025	2,098,527	5,959,850	6,263,557
Loss from operations		(1,498,817)	(1,269,666)	(4,414,479)	(4,862,684)
Other income (expense):
Change in fair value of warrant liability		(176,293)	4,047,742	1,109,192	(907,368)
Other income				390,599
Interest income (expense)		1,893	(3,728)	(736)	(2,616)
Total other income (expense)		(174,400)	4,044,014	1,499,055	(909,984)
Net income (loss)		$ (1,673,217)	$ 2,774,348	$ (2,915,424)	$ (5,772,668)
Basic net income (loss) per share(1)	[1]	$ (0.49)	$ 1.05	$ (0.90)	$ (2.26)
Diluted net loss per share(1)	[1]	$ (0.49)	$ (0.45)	$ (1.20)	$ (2.26)
Basic weighted average common shares outstanding(1)	[1]	3,432,081	2,648,240	3,245,653	2,553,930
Diluted weighted average common shares outstanding(1)	[1]	3,432,081	2,829,058	3,347,837	2,553,930

[1] Adjusted to reflect the reverse stock split of one-for-ten effective October 7, 2016.